News | May 29, 2007

Daxor to be Published In Journal of Nuclear Medicine Technology

May 30, 2007 -- Daxor Corp., a medical instrumentation and biotechnology company, announced the June 2007 publication of the Journal of Nuclear Medicine Technology article, "Blood Volume Analysis: A New Technique and New Clinical Interest Reinvigorate a Classic Study."

The article, authored by Dr. Timothy Manzone, Department of Nuclear Medicine, Christiana Care Health System and others features the fundamental concepts of a blood volume measurement and how Daxor's Blood Volume Analyzer BVA-100 and related clinical studies have demonstrated improved clinical management in heart failure, critical care and various other medical conditions.

The Journal of Nuclear Medicine Technology (JNMT) along with the Journal of Nuclear Medicine (JNM) are the most widely read peer-reviewed publications in nuclear medicine and allied disciplines. Practitioners from across the imaging sciences turn to JNMT for peer-reviewed information related to daily clinical practice.

The article reviewed the technical history of blood volume measurement and focused on the difficulty of performing an accurate and timely blood volume measurement until the introduction of Daxor's BVA-100 system.

The authors conclude that "...blood volume analysis reports of today include extraordinarily fundamental clinical parameters we could not previously measure." In addition, they state that facilities which commit to providing an automated blood volume analysis "will be rewarded and will contribute significantly to patient care."

Daxor Corp.manufactures and markets the only FDA-approved semi-automated Blood Volume Analyzer BVA-100 for the measurement of human blood volume. The Daxor BVA-100 is used in conjunction with Volumex, Daxor's single use diagnostic kit.

One of the studies cited within the article discusses how clinical assessment of the volume status of heart failure patients without a blood volume analysis is only correct 51 percent of the time, and how patients who remain volume overloaded have a two-year mortality rate of 55 percent versus a 0 percent mortality rate of patients who are treated to a normal blood volume.

The authors also note the application of blood volume measurement in the management of medical conditions in hematology, cardiology, surgery and critical care medicine.

For more information visit

Related Content

Validation Studies Confirm High Accuracy of Novel HART AI-Driven Blood Tests
News | Blood Testing | March 19, 2019
Prevencio Inc. announced data confirming the high accuracy of its artificial intelligence (AI)-driven, multiple-protein...
CoaguChek XS PT Test Strips Recalled for Inaccurately Reporting High INR
News | Blood Testing | December 28, 2018
Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche CoaguChek test strips, as...
Abbott Point-of-Care Blood Test Speeds Heart Attack Diagnosis
News | Blood Testing | October 26, 2018
For someone experiencing cardiac symptoms in the emergency room, every minute matters as physicians determine whether...
New Noninvasive Blood Glucose Test as Effective as Finger Prick

Image courtesy of University of Missouri School of Medicine

News | Blood Testing | October 24, 2018
For those living with diabetes, monitoring blood glucose accurately is necessary to prevent diabetes-related...
Abbott Receives CE Mark for High Sensitive Troponin-I Test
News | Blood Testing | October 16, 2018
October 16, 2018 — Abbott announced that its High Sensitive Troponin-I...
AI-Driven Blood Test Accurately Diagnoses Peripheral Artery Disease in Diabetic Patient
News | Blood Testing | September 04, 2018
Prevencio Inc. announced new data demonstrating its HART PAD test accurately diagnoses peripheral artery disease (PAD)...
More Sensitive Blood Test Diagnoses Heart Attacks Faster
News | Blood Testing | August 06, 2018
August 6, 2018 — A new test to assess a whether or not someone is having a...
Singulex cTnl Assay Can Identify Presence, Severity of CAD in Stable, Symptomatic Outpatients
News | Blood Testing | March 26, 2018
March 26, 2018 — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singule
Florida Medical Center First in State to Offer High Sensitive STAT Blood Test
News | Blood Testing | September 07, 2017
In July, The Heart Institute at Florida Medical Center became the first hospital in the state of Florida to offer the U...
Patients With Low Corus CAD Test Score Less Likely to Undergo Cardiac Referra
News | Blood Testing | May 02, 2017
CardioDx Inc. recently announced the publication of results from the multi-center, community-based PRESET Registry in...
Overlay Init